Identification of CRKL as an oncogenic biomarker for prognosis and immunotherapy in melanoma, and its potential molecular mechanism
Keywords
CRKL
Pan-cancer
Melanoma
Immunotherapeutic response
Pyroptosis
Data availability
The original contributions presented in the study are included in the article. Further inquiries can be directed to the corresponding authors.
© 2023 Published by Elsevier Inc.
留言 (0)